SERTOLI, MARIO ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 6.843
AS - Asia 659
NA - Nord America 249
SA - Sud America 71
AF - Africa 8
OC - Oceania 1
Totale 7.831
Nazione #
IT - Italia 6.712
SG - Singapore 293
US - Stati Uniti d'America 231
CN - Cina 191
VN - Vietnam 116
FR - Francia 55
BR - Brasile 43
FI - Finlandia 23
DE - Germania 21
HK - Hong Kong 19
AR - Argentina 10
CH - Svizzera 10
GB - Regno Unito 9
BD - Bangladesh 8
MX - Messico 8
JP - Giappone 7
CA - Canada 5
IQ - Iraq 4
PE - Perù 4
CL - Cile 3
CO - Colombia 3
ES - Italia 3
ID - Indonesia 3
IN - India 3
NL - Olanda 3
PY - Paraguay 3
SA - Arabia Saudita 3
BG - Bulgaria 2
CR - Costa Rica 2
HN - Honduras 2
KR - Corea 2
TH - Thailandia 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ET - Etiopia 1
IE - Irlanda 1
KE - Kenya 1
MA - Marocco 1
MR - Mauritania 1
PH - Filippine 1
PL - Polonia 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7.831
Città #
Genova 4.229
Genoa 1.517
Rapallo 556
Vado Ligure 392
Singapore 126
San Jose 88
Lauterbourg 52
Ashburn 41
Ho Chi Minh City 40
Hanoi 25
Helsinki 23
Beijing 20
Hong Kong 17
Frankfurt am Main 13
New York 12
Guangzhou 10
Zurich 10
Santa Clara 8
Council Bluffs 6
Haiphong 6
Tokyo 6
Bordighera 5
Los Angeles 5
Mexico City 5
Orem 5
Biên Hòa 4
Phủ Lý 4
Cardiff 3
City of London 3
Da Nang 3
Recife 3
Tianjin 3
Toronto 3
Amsterdam 2
Atlanta 2
Can Tho 2
Chennai 2
Dallas 2
Dhaka 2
Friedrichshafen 2
Jakarta 2
Milan 2
Najaf 2
New Castle 2
Rome 2
Shenzhen 2
Sóc Trăng 2
Tashkent 2
Vĩnh Tường 2
Xi'an 2
Abha 1
Abidjan 1
Aparecida de Goiânia 1
Arica 1
Baghdad 1
Bahía Blanca 1
Belo Horizonte 1
Blumenau 1
Botucatu 1
Bowling Green 1
Bremen 1
Buffalo 1
Buk-gu 1
Bình Phước 1
Bắc Ninh 1
Caaporã 1
Campodoro 1
Canoas 1
Cartago 1
Cedral 1
Cheongju-si 1
Chicago 1
Chorrillos 1
Ciudad del Este 1
Cleveland 1
Coronel Oviedo 1
Cuiabá 1
Cumming 1
Curitiba 1
Dakar 1
Damascus 1
Denver 1
Dongguan 1
Dortmund 1
Dubai 1
Dublin 1
Duque de Caxias 1
Edison 1
El Progreso 1
Elbasan 1
Fes 1
Fighiera 1
Fortaleza 1
Gastonia 1
Giessen 1
Go Vap 1
Guadalajara 1
Guarulhos 1
Haikou 1
Hatillo 1
Totale 7.327
Nome #
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years 281
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 214
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors. 213
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. 187
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 184
"Autologous Bone Marrow Transplantation for Adult Advanced Stage Lymphoblastic Lymphoma in First CR. A Study of the NHLCSG". 180
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials 175
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. 174
Gene-expression profiling in vaccine therapy and immunotherapy for cancer. 172
Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review. 168
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 168
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 165
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results 164
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 162
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials 161
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials 159
Phase II study with high-dose N5-10-methyltetrahydrofolate and 5-fluorouracil in advanced colorectal cancer. 157
84: [Antibiotic preparation in operations on the large intestine. Experimental study] GF, Rollandi GA. 155
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial 155
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis 155
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 153
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. 148
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 146
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 144
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 143
[Antibiotic preparation in operations on the large intestine. Experimental study]. 140
VACOP-B Versus VACOP-B Plus Autologous Bone Marrow Transplantation for Advanced Diffuse Non-Hodgkin's Lymphoma: Results of a Prospective Randomized Trial by the Non-Hodgkin's Lymphoma Cooperative Study Group 139
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. 137
Improved chopping of a lithium beam for plasma edge diagnostic at ASDEX Upgrade. 136
Fattibilità della Terapia Adiuvante Intraperitoneale e Sistemica in Pazienti Operati Radicalmente per Carcinoma del Colon. 135
Randomized cooperative study of perioperative chemotherapy in breast cancer. 133
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 133
Heat shock proteins and their use as anticancer vaccines. 131
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 127
Intrahepatic epidoxorubicin in metastatic and primary liver tumours: a phase II study. 126
INK4/ARF germline alterations in pancreatic cancer patients 123
Radiation-associated angiosarcoma: diagnostic and therapeutic implications--two case reports and a review of the literature. 121
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2 120
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. 120
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 120
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma. 117
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group. 112
Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancer. 109
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. 107
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma. 106
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascitis receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2) 106
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG 96
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma 95
INK4/ARF germline mutations and additional neoplasia in pancreatic cancer patients and their families 94
Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective. 93
A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer 88
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group. 86
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation. 83
La preparazione antibiotica negli interventi sul grosso intestino 76
Merkel cell carcinoma of the skin. Treatment of primary, recurrent and metastatic disease: review of clinical cases. 74
Mutazioni germinali al locus INK4/ARF in pazienti affetti da adenocarcinoma pancreatico in relazione alla storia oncologica familiare 72
La preparazione antibiotica negli interventi sul grosso intestino. Studio sperimentale 63
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer 50
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy 42
Totale 7.893
Categoria #
all - tutte 24.144
article - articoli 23.850
book - libri 0
conference - conferenze 294
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 44 22 24
2021/2022659 14 43 43 99 23 53 32 166 25 66 14 81
2022/2023655 63 56 5 79 113 114 6 41 112 1 57 8
2023/2024322 15 48 10 45 24 37 14 25 18 11 35 40
2024/20251.046 26 77 22 55 132 122 72 209 36 40 117 138
2025/20261.582 194 45 113 148 255 167 300 95 103 162 0 0
Totale 7.893